Not provided
Not provided
Not provided
Not provided
Not provided
Lockdown in the general population due to COVID
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut Pasteur | INDUSTRY |
| Pacific Community | OTHER |
| World Health Organization | OTHER |
| Institut de la Statitique et des Etudes Economiques Nouvelle Calédonie |
Not provided
Not provided
Not provided
In 2021-2022, Agence Sanitaire et Sociale Nouvelle Calédonie (ASSNC) is undertaking the "Baromètre Santé Adulte" for the third time. This study is carried out this year in collaboration with WHO and Institut Pasteur de Nouvelle Calédonie (IPNC).
The main objective of this investigation is to describe the current levels of chronic disease risk factors in the adult population of New Caledonia aged from 18 to 64 years old. This study will also help to estimate prevalence of certain diseases (diabetes, hypercholesterolemia, renal failure), seroprevalence of arboviruses (dengue fever, Zika, chikungunya and Ross River) malaria as well as the seroprevalence of SARS-CoV-2.
Repeated regularly, these surveys allow the ASS-NC to capitalize on population indicators, to compare them according to socio-demographic characteristics, to identify groups at risk, to provide changes in health behaviors and to strengthen analytical capacities in order to adapt the guidelines for public policies and prevention programs.
The "Barometre Santé Adulte" is an observational, descriptive and cross-sectional study whose data collection will take place in New Caledonia.
For this study the sampling is based on the 2019 population census, according to a 3-stage stratified sample design. In total, the main sample will consist of approximately 5,500 people (first phase) and the sub-sample will consist of 1,800 people (second phase).
The participation rate is estimated at 60%. Data collection will take place from February to May at the people's place drawn according to two steps:
All the data collected will be entered on a tablet in the eSTEPS application. The analysis of data (R Studio software) and the drafting of the report will be carried out by ASSNC staff. The first results are expected for the second half of 2022.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sample | No Intervention | questionnaires physical measurements (height, weight, perimeter abdominal and blood pressure) | |
| Sub-sample - blood test | Experimental | questionnaires physical measurements (height, weight, perimeter abdominal and blood pressure) Blood samples |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood sample | Biological | A questionnaire, physical measurements (height, weight, perimeter abdominal and blood pressure) for all arm will be done, approximately 5400 people carried out by investigators. Only 1800 will undergo blood samples carried out by nurses |
| Measure | Description | Time Frame |
|---|---|---|
| To know the prevalence of the main risk factors chronic diseases (obesity, diabetes, high blood pressure, high cholesterol and kidney failure) in the adult population of New Caledonia aged 18 to 64 using the WHO STEPS survey method. | In order to measure the prevalence of the main risk factors chronic diseases, WHO STEPS method will be used. This questionnaire is a 3 steps method, the first steps is a questionnaire mainly based on medical history and health behaviors. The second steps is associated with taking physical measurements such as weight, height, blood pressure, waist size. The last steps concerned only the experimental group "the sub-sample" for which some blood sample will be drawn out for the detection of elevated levels of blood glucose, HbA1c, total cholesterol and serum creatinine. | Within a year after recruiting the participant |
| Measure | Description | Time Frame |
|---|---|---|
| Health behaviors of the target population using the first step of the WHO STEPS survey method. | To correlate health data and everyday behaviors of the target population in order to show a trend in causal effect, in order to have specific health indicators up to date | Within a year after recruiting the participant |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Agence Sanitaire et Sociale Nouvelle Calédonie | Noumea | 98800 | New Caledonia |
Data will be share in new caledonia open data website. Data will be cleaned and anonymized prior sharing in on the open data
within 1 year after the study end
Open access
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D006937 | Hypercholesterolemia |
| D051437 | Renal Insufficiency |
| D003715 | Dengue |
| D000071243 | Zika Virus Infection |
| D065632 | Chikungunya Fever |
| D000096745 | Ross River Virus Infection |
| D008288 | Malaria |
| D045169 | Severe Acute Respiratory Syndrome |
| D002908 | Chronic Disease |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
| UNKNOWN |
This is an observational, descriptive and cross-sectional study
Not provided
Not provided
Not provided
| To calculate the cardiovascular risk of the New Caledonian population using the SCORE projet |
To calculate the cardiovascular risk based on systolic blood pressure, sex, smoking status and cholesterol level. |
| Within a year after recruiting the participant |
| Seroprevalence of infectious diseases | To Determine the seroprevalence of dengue, Zika, chikungunya and Ross River arboviruses in New Caledonia, the seroprevalence against the malaria agent as well as the seroprevalence of SARS-CoV-2. | Within a year after recruiting the participant |
| D006949 | Hyperlipidemias |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D000096724 | Mosquito-Borne Diseases |
| D000079426 | Vector Borne Diseases |
| D007239 | Infections |
| D001102 | Arbovirus Infections |
| D014777 | Virus Diseases |
| D018177 | Flavivirus Infections |
| D018178 | Flaviviridae Infections |
| D012327 | RNA Virus Infections |
| D006482 | Hemorrhagic Fevers, Viral |
| D018354 | Alphavirus Infections |
| D014036 | Togaviridae Infections |
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
| D012141 | Respiratory Tract Infections |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012140 | Respiratory Tract Diseases |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |